NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for chemotherapeutic agent


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on cancer discussed by researchers at Harvard University, Medical Department
2009 NOV 16 ... different types of breast cancer. The combination of metformin and a well-defined chemotherapeutic agent, doxorubicin, kills both cancer stem cells and non-stem cancer cells in culture. ...
Subject: Cancer
Price: $3.00
*
New findings from A.Y. Grahn and co-authors in the area of glioma published
2009 NOV 23 ... "Convection-enhanced delivery (CED) of highly stable PEGylated liposomes encapsulating chemotherapeutic drugs has previously been effective against malignant glioma xenografts. We have ... with gadoCED showed no evidence of histopathological changes attributable to either agent," wrote A.Y. Grahn and colleagues. The researchers concluded: "The ...
Subject: Glioma
Price: $3.00
*
New findings from L. Holle and co-researchers in the area of fusion proteins described
2009 NOV 9 ... "Chemotherapy is one of the main treatment options for cancer, but the effectiveness of chemotherapeutic drugs is severely limited due to their systemic toxicity. Therefore, the need for a more ... more targeted approach in tumor treatment is obvious." "A tumor-activated agent would decrease systemic toxicity as well as increase the efficacy of the treatment. It ...
Subject: Fusion Proteins
Price: $3.00
*
Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
2009 NOV 9 ... that it has been granted its 33rd U.S. Patent, # 7,608,257, entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus." The patent claims cover methods of using ...
Subject: Patents
Price: $3.00
*
Reports on dielectrics and electrical insulation findings from University of Zagreb provide new insights
2009 NOV 25 ... drugs, DNA) into target cells in vivo. Electrochemotherapy involves the injection of chemotherapeutic agent followed by a local delivery of a train of short high-voltage pulses to the tumor nodule ...
Subject: Dielectrics and Electrical Insulation
Price: $3.00
*
Research data from Massachusetts General Hospital update understanding of chordoma
2009 NOV 16 ... lines after treatment with SD-1029. The cytotoxicity of the combination of SD-1029 and chemotherapeutic drugs is significantly better than either agent alone. Phosphorylation of Stat3 in ...
Subject: Chordoma
Price: $3.00
*
Research from St. Louis University, Medical Department has provided new information about apoptosis
2009 NOV 9 ... growth in the small interfering UCKL-1 RNA treated K562 cell culture. In addition, the chemotherapeutic agent staurosporine was seen to be more effective in inducing cell death by apoptosis in ...
Subject: Apoptosis
Price: $3.00
*
Research on clinical trial research reported by E. Demirkaya et al
2009 NOV 23 ... "Doxorubicin (DXR) is a chemotherapeutic agent used effectively in the treatment of several childhood malignancies. During treatment, ...
Subject: Clinical Trial Research
Price: $3.00
*
Research on reovirus described by scientists at University of Surrey
2009 NOV 16 ... response to reovirus in vitro and in vivo. The combination of reovirus and several chemotherapeutic agents synergistically enhanced cytotoxicity in human and murine melanoma cell lines in ... versus combination treatments was completed using the Agilent microarray system. Single agent and combination therapy effects were tested in vivo in two immunocompetent models of ...
Subject: Reovirus
Price: $3.00
*
Research reports on kidneys from Chonbuk National University, Medical Department provide new insights
2009 NOV 9 ... According to a study from South Korea, "Cisplatin is a chemotherapeutic agent used in treatment of malignant tumours. However, cisplatin produces various side ...
Subject: Kidneys
Price: $3.00
*
Researchers at Zhengzhou University release new data on pharmacokinetics
2009 NOV 23 ... Republic of China, "2-Methoxyestradiol is currently in phase II clinical trials as a chemotherapeutic agent. An LC method with fluorescence detection was developed for determination of ...
Subject: Pharmacokinetics
Price: $3.00
*
Researchers' work from Ohio State University focuses on pancreatic cancer
2009 NOV 9 ... has numerous anti-carcinogenic properties, but low bioavailability prevents its use in chemotherapeutic applications. One strategy for circumventing this problem has been the creation of ... of cell viability and STAT3 activation, and may thus have potential as a therapeutic agent for cancers expressing high levels of activated STAT3." Hutzen and ...
Subject: Pancreatic Cancer
Price: $3.00
*
Scientists at National Taiwan University release new data on hepatocellular cancer
2009 NOV 16 ... the deliberation that the resistance can be caused during combined administration of chemotherapeutic drugs and Chinese herbal medicines, which induce endoplasmic reticulum stress and/or ... arrest contributed to the resistance mechanism. Curcumin, another G1 arrest-inducing agent in this study, was able to induce a similar resistant effect. Furthermore, the cells ...
Subject: Hepatocellular Cancer
Price: $3.00
*
Scientists at State University of New York publish research in reproductive science
2009 NOV 10 ... bursting, varies in the different cells of the ovary. Cisplatin is a broadly used chemotherapeutic agent that results in ovarian damage." "The objective of this study was to test ...
Subject: Reproductive Science
Price: $3.00
*
Scientists at University of Texas publish research in breast cancer
2009 NOV 23 ... research published in the journal Experimental Biology and Medicine, "Paclitaxel is a chemotherapeutic agent used for the treatment of metastatic breast cancer. 2,5,7,8-Tetramethyl-2R-(4R, ...
Subject: Breast Cancer
Price: $3.00
*
Studies from C.C. Chiu and co-authors have provided new information about lung cancer
2009 NOV 16 ... The researchers concluded: "These results suggest protoapigenone is a potential chemotherapeutic agent for lung cancers." Chiu and colleagues published their study in DNA and ...
Subject: Lung Cancer
Price: $3.00
*
Studies from Dongeui University, Medical Department have provided new information about leukemia
2009 NOV 9 ... apoptosis in U937 cells; these findings suggest that schisandrin C may be a useful chemotherapeutic agent." Park and colleagues published their study in International Journal of ...
Subject: Leukemia
Price: $3.00
*
Study results from D. Ng et al provide new insights into biotechnology
2009 NOV 16 ... a strategy to increase the production of ansamitocin-P3 (AP-3), a clinically promising chemotherapeutic agent. Putative transcriptional regulators asm2, asm29, and asm34 as well as the putative ...
Subject: Biotechnology
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... There is an urgent need for new treatments for patients with prostate cancer since these chemotherapeutic agents extend survival for only a few months," said Philip Kantoff, M.D., chief ... demonstrated improved efficacy compared with any individual therapy or investigational agent in development to treat prostate cancer. "For patients suffering from ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login